Pilot-scale production of human serum butyrylcholinesterase suitable for use as a bioscavenger against nerve agent toxicity

Process Biochemistry

Volumn 45, Issue 8, 2010, Pages 1313-1318

  Saxena, Ashima ^a   Tipparaju, Prasanthi ^a   Luo, Chunyuan ^a   Doctor, Bhupendra P ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Bioscavenger; Cohn fraction IV 4; Human serum butyrylcholinesterase; Organophosphorus nerve agents; Pilot scale production

Indexed keywords

ANION EXCHANGE CHROMATOGRAPHY; BUTYRYLCHOLINESTERASE; CLINICAL STUDY; GRAM QUANTITIES; HIGH YIELD; HUMAN SERUM; MANUFACTURING PROCEDURE; NERVE AGENTS; PILOT SCALE; PILOT-SCALE PRODUCTION; PRE-CLINICAL; PURIFIED ENZYME; RE-SUSPENSION; SDS-PAGE; SPECIFIC ACTIVITY;

ENZYMES; PURIFICATION; TOXICITY;

BODY FLUIDS;

EID: 77954085821     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2010.04.021     Document Type: Article

References (21)

1. Saxena A., Luo C., Chilukuri N., Maxwell D.M., Doctor B.P. Novel approaches to medical protection against chemical warfare nerve agents. Chemical warfare agents chemistry, pharmacology, and therapeutics 2007, 145-173. CRC Press, Boca Raton, FL. J.A. Romano, B.J. Lukey, H. Salem (Eds.).
2. Stovner J., Stadskleiv K. Suxamethonium apnea terminated with commercial serum cholinesterase. Acta Anaesthesiol Scand 1976, 20:211-215.
3. Hoffman R.S., Morasco R., Goldfrank L.R. Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol 1996, 34:259-266.
4. Carmona G.N., Schindler C.W., Shoaib M., Jufer R., Cone E.J., Goldberg S.R., et al. Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase. Exp Clin Psychopharmacol 1998, 6:274-279.
5. Duysen E.G., Bartels C.F., Lockridge O. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity. J Pharmacol Exp Ther 2002, 302:751-758.
6. Ashani Y. Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugs. Drug Dev Res 2000, 50:298-308.
7. Ralston J.C., Main A.R., Kilpatrick B.F., Chasson A.L. Use of procainamide gels in the purification of human and horse serum cholinesterases. Biochem J 1983, 211:243-250.
8. Lockridge O. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 1990, 47:35-60.
9. Grunwald J., Marcus M., Papier Y., Raveh L., Pittel Z., Ashani Y. Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods 1997, 34:123-135.
10. Lockridge O., Schopfer L.M., Winger G., Woods J.H. Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity. J Med Chem Biol Radiol Def 2005, 3. nihms 5095.
11. Surgenor D.M., Ellis D. Preparation and properties 4of serum and plasma proteins. Plasma cholinesterase. J Am Chem Soc 1954, 76:6049-6051.
12. Mattes C.E., Bradley R., Slaughter E., Browne S. Cocaine and butyrylcholinesterase (BChE): determination of enzymatic parameters. Life Sci 1996, 58:257-261.
13. Lynch TJ. Production of butyrylcholinesterase. US Patent No. 5,272,080; 1993.
14. Saxena A., Luo C., Doctor B.P. Developing procedures for the large-scale purification of human serum butyrylcholinesterase. Protein Expr Purif 2008, 61:191-196.
15. Ellman G.L., Cortney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetycholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
16. Karnovsky M.J., Roots L. A direct-coloring thiocholine method for cholinesterases. J Histochem Cytochem 1964, 12:219-221.
17. Laemmeli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
18. Saxena A., Sun W., Luo C., Doctor B.P. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 2005, 157-158:199-203.
19. Lockridge O., Eckerson H.W., La Du B.N. Interchain disulfide bonds and subunit organization in human serum cholinesterase. J Biol Chem 1979, 254:8324-8330.
20. Saxena A., Ashani Y., Raveh L., Stevenson D., Patel T., Doctor B.P. Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. Mol Pharmacol 1998, 53:112-122.
21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm%3FCFRPar.